OncoMed Pharma (OMED) Misses Q2 EPS by 10c

August 9, 2016 5:09 PM EDT
Get Alerts OMED Hot Sheet
Trade OMED Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

OncoMed Pharma (NASDAQ: OMED) reported Q2 EPS of ($0.91), $0.10 worse than the analyst estimate of ($0.81). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $8.09 million.

For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment